Palisade Bio (PALI) Accumulated Expenses (2010 - 2026)
Palisade Bio (PALI) reported Accumulated Expenses of $122000.0 for Q1 2026, up 3.39% year-over-year from $118000.0 in Q1 2025, and down 90.6% quarter-over-quarter from $1.3 million in Q4 2025.
Palisade Bio (PALI) Accumulated Expenses (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 16 years of Accumulated Expenses data on file, last reported at $122000.0 in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $122000.0, up 3.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $122000.0 (up 3.39% YoY), and the FY2025 annual result was $1.3 million, up 4.68% from the prior year.
- Accumulated Expenses slipped to $122000.0 in Q1 2026 per PALI's latest filing, from $1.3 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.7 million in Q1 2024 and troughed at $118000.0 in Q1 2025.
- A 5-year average of $662941.2 and a median of $574000.0 in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 774.35% in 2024, then plunged 92.93% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $574000.0 in 2022, then soared by 44.77% to $831000.0 in 2023, then surged by 49.22% to $1.2 million in 2024, then rose by 4.68% to $1.3 million in 2025, then sank by 90.6% to $122000.0 in 2026.
- Business Quant data shows PALI's Accumulated Expenses at $122000.0 in Q1 2026, $1.3 million in Q4 2025, and $621000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 449,000.00 |
| Jun 30, 2024 | 288,000.00 |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 831,000.00 |
| Sep 30, 2023 | 529,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 191,000.00 |
| Dec 31, 2022 | 574,000.00 |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 580,000.00 |
| Dec 31, 2021 | 463,000.00 |
| Sep 30, 2021 | 722,000.00 |
| Jun 30, 2021 | 164,000.00 |